Workflow
1 Top Growth Stock Down 50% to Buy After Its Recent Pullback
TMDXTransMedics(TMDX) The Motley Fool·2024-11-04 12:15

TransMedics quickly became the leader in liver, heart, and lung transplants, but its third-quarter earnings left the market worried. Here's why I believe its pullback in share price is an opportunity. TransMedics (TMDX 0.53%) is on a mission to revolutionize the organ transplant process. Thanks to the company's Organ Care System (OCS), TransMedics' equipment essentially keeps donated livers, hearts, and lungs "functioning" as they are en route to their donee. Powered by this incredibly important capability, ...